You're in the EP lab. The patient on the table has had a dual-chamber pacemaker for three years — complete heart block, post-AVR. Now they've had a syncopal episode. EP study shows inducible sustained monomorphic VT. But the plan: ICD for secondary prevention. ATP will be the first-line therapy for VT.
Not the most exciting part, but easily the most useful.
But there's already a device in the chest. Two leads in the heart. A generator in the pectoral pocket.
Now what?
This scenario plays out more often than textbooks suggest. They need ICDs. Pacemaker patients develop cardiomyopathy. They survive MIs. And suddenly you're managing two devices, two lead systems, and a programming puzzle that doesn't exist in the guidelines.
Here's how it actually works — and where people get tripped up.
What Is ATP and Why Does It Matter Here
Anti-tachycardia pacing isn't shocking. On the flip side, it's overdrive pacing — a burst of rapid stimuli faster than the tachycardia cycle length, designed to penetrate the reentrant circuit and break the loop. Because of that, no patient awareness. No high-voltage capacitor charge. No myocardial stunning Still holds up..
In a native ICD, ATP is straightforward. The device detects VT, confirms it's not SVT, delivers a programmed burst (or ramp, or scan), and checks for termination. If it fails, it escalates to shock Turns out it matters..
But add a pre-existing pacemaker, and three things change immediately:
- Sensing territory overlaps — the pacemaker's ventricular lead sits in the RV apex. The ICD's RV coil/lead does too. They're listening to the same electrogram.
- Pacing output conflicts — the pacemaker might pace during the ICD's ATP sequence. Or inhibit. Or trigger crosstalk.
- No unified logic — two separate microprocessors, two separate algorithms, zero communication between them.
That last one is the kicker. The pacemaker doesn't know the ICD is delivering ATP. The ICD doesn't know the pacemaker just paced at 60 bpm during a VT episode That's the part that actually makes a difference. Worth knowing..
Why This Comes Up More Than You Think
Guidelines say "upgrade to ICD." Simple on paper. In practice, you're staring at:
- A 78-year-old with a 4-year-old dual-chamber PM, fractional RV pacing, now with ischemic CM (EF 28%) and non-sustained VT on monitor
- A 55-year-old with congenital complete heart block, pacemaker since age 12, now with hypertrophic cardiomyopathy and syncope
- A post-TAVR patient with new LBBB, permanent pacemaker at 3 months, now with VT storm at 9 months
The "just upgrade" approach means lead extraction. Still, which means:
- Extraction risk (vascular tear, tricuspid valve damage, mortality 0. 5–1.
So the question becomes: can you implant a de novo ICD alongside the existing pacemaker — and make ATP work reliably?
Short answer: yes. But it takes deliberate programming, not hope.
How to Approach the Dual-Device Implant
Pocket and lead geometry
Most operators place the ICD generator in the contralateral pectoral pocket. Left PM → right ICD. Or submuscular vs. subpectoral separation on the same side if anatomy demands.
RV leads: the pacemaker's ventricular lead stays. The ICD gets its own RV lead — typically a true bipolar sensing/pacing lead with a shock coil (DF4 or DF1). This lead handles both brady pacing backup and ATP/shock delivery.
Key decision: does the ICD lead replace the PM's ventricular pacing function?
Option A: **ICD takes over all ventricular pacing.Practically speaking, ** Program the PM to VVI 30 bpm (or OVO/DOOR mode if manufacturer supports). Cleanest electrophysiologically. ICD handles AV synchrony, rate response, CRT if needed. But you lose the PM's atrial lead for tracking unless you use a dual-chamber ICD Turns out it matters..
Option B: **PM keeps ventricular pacing; ICD is backup only.1V/0.1ms (effectively off). ** ICD ventricular pacing output set to 0.On the flip side, iCD senses only. ATP and shock still work. But now you have two active pacers in the RV — and the PM doesn't know when the ICD fires ATP But it adds up..
Option C: **S-ICD + keep PM entirely separate.Also, ** No transvenous ICD lead. ATP not available — only shock. Also, valid for patients where ATP is low-yield (very fast VT, structural scar with low ATP success) or extraction risk is prohibitive. But you lose the single most effective painless therapy.
Most EP labs lean Option A with a dual-chamber ICD. So one device doing everything. The old PM becomes a "ghost" — generator explanted or left abandoned (capped), atrial lead reused if compatible, ventricular lead capped/abandoned Simple as that..
But what if you can't extract? Frail patient. Hostile anatomy. Failed prior extraction. Then you're in Option B territory — two live devices.
Making ATP work with two active devices
At its core, where the programming earns its keep.
1. Sensing configuration — eliminate double-counting
The ICD's RV lead senses the PM's pacing spikes. Plus, during VT, the PM might pace (if not inhibited) or be inhibited. If the PM paces at 60 bpm during sinus rhythm, the ICD sees 120 bpm (spike + T-wave). Either way, the ICD's sensing algorithm must reject the PM's artifacts.
Solution: true bipolar sensing on the ICD lead (tip-to-ring, 10–15 mm spacing). Program sensitivity to least sensitive setting that still detects VF (typically 0.In real terms, 3–0. Enable pacing artifact rejection algorithms (Boston Scientific's "Pacing Artifact Rejection," Medtronic's "Smart Sense," Abbott's "AutoSense"). 5 mV). Test during implant: pace from PM at max output, confirm ICD doesn't double-count.
2. ATP triggering — prevent PM interference
When the ICD charges for ATP, it enters a "therapy delivery" window. If the PM fires a ventricular pace during that window, two things can happen:
- The PM's pace captures the ventricle → resets the reentrant circuit → ATP fails
- The PM's pace falls in the vulnerable window → initiates VF (theoretical but real)
This is where a lot of people lose the thread That alone is useful..
Solution: **program the PM to VVI 30 bpm (or OFF) during ICD therapy.But magnets also disable ICD therapies. ** Most modern PMs have a "magnet mode" or "therapy inhibition" feature triggered by a reed switch. Not ideal.
Better: use the ICD's "pre-therapy pacing" or "pre-shock pacing" window to overdrive the PM. Program the ICD to deliver a brief burst of pacing at 80–90 ppm before ATP — this captures the ventricle, suppresses the PM (via retrograde concealment or fusion
or simply overrides the PM's intrinsic/paced rhythm), and effectively "cleans up" the rhythm before the ICD attempts to terminate the arrhythmia. This creates a predictable electrical environment for the ICD's sensing and therapy algorithms.
3. The "Capture" Dilemma: Ensuring the ICD is in control
If the PM is pacing at a rate close to the ICD's detection threshold, the ICD may misinterpret the PM's pacing spikes as an arrhythmia (oversensing) or fail to detect the actual VT because the PM's pacing is masking the morphology (undersensing).
Solution: Prioritize ICD sensing. During the procedure, ensure the ICD lead is placed in a position with optimal morphology and sensing characteristics. If the PM must remain active, it should be programmed to a rate significantly lower than the ICD's VT detection threshold (e.And g. , 50–60 bpm) to make sure any rhythm change detected by the ICD is clearly attributable to the patient's underlying rhythm and not the PM's pacing spikes.
And yeah — that's actually more nuanced than it sounds.
Clinical Decision Summary
Choosing the right strategy for a patient with an existing pacemaker and a new requirement for ICD therapy requires a careful risk-benefit analysis of the following factors:
- Extraction Risk: If the risk of lead extraction (infection, cardiac perforation, vascular complications) is high, Option B (Dual Device) or Option C (S-ICD) becomes the safer, albeit more complex, choice.
- Therapy Requirements: If the patient has a high burden of VT that is highly responsive to anti-tachycardia pacing (ATP), Option A (Single Device) is the gold standard to provide the most painless and effective therapy.
- Anatomy and Device Compatibility: The presence of existing leads, the patient's venous anatomy, and the compatibility of the old leads with the new ICD's sensing requirements must be meticulously evaluated during the pre-operative planning.
Pulling it all together, managing the "dual-device" scenario is a sophisticated task that moves beyond simple implantation into the realm of advanced electrophysiological programming. On top of that, whether an EP chooses to consolidate into a single device or manage two separate systems, the goal remains the same: providing solid, reliable, and life-saving therapy while minimizing the risks of inappropriate shocks and failed ATP. Success in these complex cases depends on meticulous intraoperative testing, an intimate understanding of device-specific algorithms, and a personalized approach to each patient's unique anatomy and clinical needs.
And yeah — that's actually more nuanced than it sounds.
